Active Ingredient History

  • Now
Fumazenil is an imidazobenzodiazepine derivative and a potent benzodiazepine receptor antagonist that competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex, thereby reversing the effects of benzodiazepine on the central nervous system. Fumazenil is used for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, and where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures. Also for the management of benzodiazepine overdose as an adjunct for appropriate supportive and symptomatic measures. Flumazenil went off patent in 2008 so at present generic formulations of this drug are available.   NCATS

  • Mol. Mass: 303.2884
  • ALogP: 1.77
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$0.9830 - $3.1060
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

11c-flumazenil | anexate | flumazenil | flumazenilo | flumazenilum | flumazepil | lanexat | mazicon | mazicon | ro-151788 | ro-15-1788 | ro-151788000 | romazicon


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue